athagoras MedTech highlights Spain's 2026 HTA agenda focusing on newborn screening and metabolic conditions.

athagoras MedTech enables you to navigate regulatory, evidence and market access pathways with clarity, alignment and confidence across Europe, the UK and Switzerland. We work alongside your teams to design solutions that are not only sound on paper, but hold up in real-world decision-making and local implementation. From day one, we think end-to-end - so you can plan with confidence, align stakeholders internally, and deliver outcomes that are robust, defensible and executable. We are a specialised MedTech consulting partner supporting medical devices, diagnostics, digital health and combination products across their full lifecycle - from strategy through to execution at EU, UK and country level. Rather than operating at arm’s length, we integrate into your teams, bringing the missing expertise needed to connect regulatory, clinical, quality and market access functions and avoid fragmentation. Our approach combines deep local expertise with a European perspective, ensuring that strategies translate into practical implementation across markets. Our teams bring experience from industry, consulting and academia, combining strategic insight with hands-on delivery and accountability for outcomes. We support you across: - Regulatory strategy and submissions (EU MDR, IVDR, UKCA and international pathways) - Clinical and evidence strategies, including real-world evidence (RWE) - Health economics, pricing and reimbursement across European systems - Local market access execution, HTA and stakeholder engagement - Quality systems and cross-functional process alignment Whether you need targeted expertise or an integrated end-to-end partner, we adapt to your needs - with one objective: enabling better decisions and successful, sustainable adoption of your technology in healthcare systems. Visit our website to connect and optimise your market access strategy together!